Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors - PubMed (original) (raw)
Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors
T Kusaba et al. J Clin Pathol. 2005 Aug.
Abstract
Background: The signal transducer and activator of transcription 3 (STAT3) is a key signalling molecule implicated in the regulation of growth and malignant transformation. Constitutive activation of STAT3 is seen in several tumour derived cell lines, and in a wide variety of human malignancies.
Aims: To examine the relation between p-STAT3 (activated form of STAT3) expression and clinicopathological factors in human colorectal adenocarcinoma and adenoma.
Methods: Immunohistochemical analyses were carried out on tissues from 44 colorectal adenomas and 95 colorectal adenocarcinomas, comprising 18 intramucosal carcinomas and 77 invasive carcinomas.
Results: Seventy seven of these 139 samples (55.4%) showed immunoreactivity for p-STAT3. Positive staining for p-STAT3 was seen in 69 of the 95 carcinomas. Only eight of the 44 adenomas showed immunopositivity for p-STAT3, resulting in a significant difference between total adenocarcinomas and adenomas (p < 0.001). Among the 95 cases of colorectal adenocarcinoma, p-STAT3 immunoreactivity was significantly correlated with the depth of tumour invasion (p < 0.05), venous invasion (p < 0.05), lymph node metastasis (p < 0.05), and increasing stages of the Dukes' classification (p < 0.01). Expression of p-STAT3 was detected by Western blot analysis in two different cultured human colorectal carcinoma cell lines and six colon carcinoma tissue samples obtained at surgery.
Conclusion: This is the first study to report a significant correlation of p-STAT3 expression with the depth of tumour invasion. These findings suggest that p-STAT3 expression is an important factor related to carcinogenesis and/or tumour invasion of colorectal adenocarcinoma.
Figures
Figure 1
(A) Immunohistochemistry for phosphorylated (activated) signal transducer and activator of transcription (p-STAT3) in colorectal adenocarcinomas. p-STAT3 shows strong nuclear and cytoplasmic expression. (immunoalkaline phosphatase staining; original magnification, ×400). (B) Expression of p-STAT3 was seen in all layers of this adenocarcinoma (immunoalkaline phosphatase staining; original magnification, ×10).
Figure 2
In almost all of the carcinomas studied, the intensity of phosphorylated (activated) signal transducer and activator of transcription (p-STAT3) expression was stronger in the deeper parts of invasion than in the superficial areas. (A) Expression of p-STAT3 in a carcinoma invading the submucosa (original magnification, ×60). (B) (original magnification, 60×). Expression of p-STAT3 in a carcinoma invading the muscularis propria. (C) Expression of p-STAT3 in a carcinoma invading the subserosa (original magnification, ×60).
Figure 3
The expression of phosphorylated (activated) signal transducer and activator of transcription (p-STAT3) is lower in normal mucosa (lanes 1 and 2) than in adenocarcinoma (lanes 3–8). There is no difference in the expression of STAT3 between the normal mucosa and carcinoma tissues. β Actin was used as an internal protein control.
Figure 4
Phosphorylated (activated) signal transducer and activator of transcription (p-STAT3) is constitutively expressed without interferon α (IFNα) stimulation in the DLD-1 cell line. Colo320DM expressed p-STAT3 only after the stimulation with IFNα.
Similar articles
- Activation of STAT3 is a marker of poor prognosis in human colorectal cancer.
Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, Nagayasu T, Sekine I. Kusaba T, et al. Oncol Rep. 2006 Jun;15(6):1445-51. Oncol Rep. 2006. PMID: 16685378 - The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK. Kasem K, et al. Exp Cell Res. 2014 Aug 1;326(1):166-73. doi: 10.1016/j.yexcr.2014.06.013. Epub 2014 Jun 25. Exp Cell Res. 2014. PMID: 24973512 - Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
Takahashi H, Wang JP, Zheng HC, Masuda S, Takano Y. Takahashi H, et al. Histol Histopathol. 2011 Jun;26(6):663-71. doi: 10.14670/HH-26.663. Histol Histopathol. 2011. PMID: 21472681 - The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K, Zhang M, Chu Q, Gan Y, Ren H, Zhang L, Wang L, Li X, Wang W. Ji K, et al. PLoS One. 2016 Aug 9;11(8):e0160125. doi: 10.1371/journal.pone.0160125. eCollection 2016. PLoS One. 2016. PMID: 27504822 Free PMC article. Review. - Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
Sakashita M, Aoyama N, Minami R, Maekawa S, Kuroda K, Shirasaka D, Ichihara T, Kuroda Y, Maeda S, Kasuga M. Sakashita M, et al. Eur J Cancer. 2001 Jan;37(2):204-9. doi: 10.1016/s0959-8049(00)00371-3. Eur J Cancer. 2001. PMID: 11166147 Review.
Cited by
- Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling.
Fu Q, Jiang Y, Zhang D, Liu X, Guo J, Zhao J. Fu Q, et al. Mol Cell Biochem. 2016 Jul;418(1-2):189-98. doi: 10.1007/s11010-016-2746-6. Epub 2016 Jun 25. Mol Cell Biochem. 2016. PMID: 27344168 Free PMC article. - Stat3 is indispensable for damage-induced crypt regeneration but not for Wnt-driven intestinal tumorigenesis.
Oshima H, Kok SY, Nakayama M, Murakami K, Voon DC, Kimura T, Oshima M. Oshima H, et al. FASEB J. 2019 Feb;33(2):1873-1886. doi: 10.1096/fj.201801176R. Epub 2018 Aug 29. FASEB J. 2019. PMID: 30156908 Free PMC article. - Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation.
Chen Y, Sun L, Li D, Yin X, Shang G, Diao T, Shi L. Chen Y, et al. Turk J Gastroenterol. 2022 Sep;33(9):731-742. doi: 10.5152/tjg.2022.21855. Turk J Gastroenterol. 2022. PMID: 35946886 Free PMC article. - LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.
Leve F, Peres-Moreira RJ, Binato R, Abdelhay E, Morgado-Díaz JA. Leve F, et al. PLoS One. 2015 Sep 29;10(9):e0139094. doi: 10.1371/journal.pone.0139094. eCollection 2015. PLoS One. 2015. PMID: 26418031 Free PMC article. - Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling.
Du J, Wu J, Fu X, Tse AK, Li T, Su T, Yu ZL. Du J, et al. Oncotarget. 2016 Aug 9;7(32):52218-52229. doi: 10.18632/oncotarget.10582. Oncotarget. 2016. PMID: 27418138 Free PMC article.
References
- Newland RC, Dent OF, Lyttle MN, et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076–82. - PubMed
- Steinberg SM, Barwick KW, Stablein DM. Importance of tumour pathology and morphology in patients with surgically resected colon cancer. Cancer 1986;58:1340–45. - PubMed
- Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630–35. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous